Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > CND company Greenrise Global Brands Inc. sells Dronabinol
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Post by SamV21on Nov 05, 2022 11:07pm
417 Views
Post# 35076594

CND company Greenrise Global Brands Inc. sells Dronabinol

CND company Greenrise Global Brands Inc. sells DronabinolIn Germany   dronabinol medical cannabis product available in pharmacies beginning in January 2022.Greenrise Global Brands Inc. trades at .11 cents.
There are 84,000,000 people in Germany and not even 40,000,000 people in Canada .
Plus https://mjbizdaily.com/tilray-adds-dronabinol-to-german-product-portfolio/
Tilray is selling Dronabinol in Germany as well.
Canopy Growth also is selling Dronabinol in other parts of the world. Once again Guy has mist the bus and is about to get run over . He is just copying what the big boys are doing with deep pockets to finish what they start .DRONABINOL WILL NOT SAVE TETRA , ONLY BUY IF YOU ARE PREPARED TO PUT MORE MONEY INTO GUYS SCAM . Broke is Broke there will be a halt .Guy has never , never ever given us net numbers on Redvo even if he does get approval, he also has no money to launch it even if it is approved ,he is not qualified to do anything but collect money with no results and suck people into his old science dreams.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities